Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (161-170 of 367) with videos related to

Pageof 37
Sort By:
Thrombosis Research|April 30, 2013
Response to antiplatelet therapy is independent of endogenous thrombin generation potentialThomas Gremmel, Simon Panzer, Sabine Steiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2015
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)Florian Posch, Johannes Thaler, Gerhard-Johann Zlabinger, et al.
Thrombosis Journal|December 1, 2022
Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort studyDaniel Steiner, Sabine Schmaldienst, Matthias Lorenz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2022
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI studyStephan Nopp, Oliver Königsbrügge, Sabine Schmaldienst, et al.
BMC Medicine|March 11, 2017
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulantFlorian Posch, Johanna Gebhart, Jacob H Rand, et al.
Blood|August 4, 2012
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patientsElena Santagostino, Claude Negrier, Robert Klamroth, et al.
Thrombosis and Haemostasis|September 6, 2006
Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancyGuelay Alguel, Rainer Vormittag, Ralph Simanek, et al.
Annals of Hematology|July 20, 2007
Platelet glycoprotein Ibalpha polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic diseasePetra Jilma-Stohlawetz, Bernd Jilma, Christine Mannhalter, et al.
Haematologica|May 26, 2018
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancerElla Grilz, Oliver Königsbrügge, Florian Posch, et al.
Thrombosis Research|March 10, 2012
Identification of an ancient haemophilia A splice site mutationSylvia Reitter-Pfoertner, Arndt von Haeseler, Birgit Horvath, et al.
Pageof 37

Showing results (161-170 of 367) with videos related to

Sort By:
Pageof 37
Thrombosis Research|April 30, 2013
Response to antiplatelet therapy is independent of endogenous thrombin generation potentialThomas Gremmel, Simon Panzer, Sabine Steiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2015
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)Florian Posch, Johannes Thaler, Gerhard-Johann Zlabinger, et al.
Thrombosis Journal|December 1, 2022
Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort studyDaniel Steiner, Sabine Schmaldienst, Matthias Lorenz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2022
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI studyStephan Nopp, Oliver Königsbrügge, Sabine Schmaldienst, et al.
BMC Medicine|March 11, 2017
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulantFlorian Posch, Johanna Gebhart, Jacob H Rand, et al.
Blood|August 4, 2012
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patientsElena Santagostino, Claude Negrier, Robert Klamroth, et al.
Thrombosis and Haemostasis|September 6, 2006
Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancyGuelay Alguel, Rainer Vormittag, Ralph Simanek, et al.
Annals of Hematology|July 20, 2007
Platelet glycoprotein Ibalpha polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic diseasePetra Jilma-Stohlawetz, Bernd Jilma, Christine Mannhalter, et al.
Haematologica|May 26, 2018
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancerElla Grilz, Oliver Königsbrügge, Florian Posch, et al.
Thrombosis Research|March 10, 2012
Identification of an ancient haemophilia A splice site mutationSylvia Reitter-Pfoertner, Arndt von Haeseler, Birgit Horvath, et al.
Pageof 37